
Covance Not Cooling...


| Price and Volume | |
|---|---|
| Recent Price | 73.54 |
| 52 Week High | 73.85 |
| 52 Week Low | 39.73 |
| Avg. Daily Vol. (Mil) | 3.56 |
| Beta (3 year) | 1.28 |
| Share Related Items | |
| Mkt Cap (Mil) | 12,654.56 |
| Shares Out (Mil) | 172.08 |
| Float (Mil) | 170.09 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.60 |
| LT Debt/ Equity | 0.47 |
| Total Debt / Equity | 0.54 |
| Valuation Ratios | |
| Price Earnings | 31.30 |
| Price/Sales | 3.31 |
| Price/Book | 2.70 |
| Price/Cash Flow | 12.80 |
| Per Share Data | |
| Earnings | 2.35 |
| Sales | 22.21 |
| Book Value | 27.23 |
| Cash Flow | 5.75 |
| Business Summary | |
|---|---|
| Life Technologies Corporation is a global life sciences company dedicated to helping its customers make scientific discoveries and applying those discoveries to ultimately improve the quality of life. | |
| General Information | |
| 5791 Van Allen Way
Carlsbad, CA 92008 |
|
| www.invitrogen.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 10000 | |
| CEO: Gregory T. Lucier | |
| Short Interest | |
| Current Month (Mil) | 2.06 |
| Previous Month (Mil) | 2.61 |
| Short Interest Ratio (Days) | 0.30 |
| Management Effectiveness | |
| Return on Equity | 11.80 |
| Return on Assets | 6.50 |
| Return on Investments | 8.00 |
| Profitability | |
| Gross Margin | 67.60 |
| EBIT Margin | 16.90 |
| Profit Margin | 14.40 |